Understanding Farydak® (panobinostat) capsules

Farydak® (panobinostat) is the first histone deacetylase (HDAC) inhibitor approved for use in treating myeloma. Farydak® is taken in capsule form in combination with Velcade® (bortezomib) and dexamethasone by patients who have already been treated with Velcade® and an immunomodulatory drug.
Purchase this product
FREE